{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:27:36Z","timestamp":1763512056091,"version":"3.45.0"},"posted":{"date-parts":[[2025,9,30]]},"group-title":"In Review","reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,9,17]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Recombinant vaccines are a cornerstone of global health, exemplified by the eradication of type 3 wild poliovirus in 2020 due to extensive vaccination campaigns. However, sequence similarity between vaccine antigens and human proteins could theoretically risk autoimmune reactions via molecular mimicry. We present the \u2018Vaccine Candidate de-Risking and Stabilisation\u2019 (VaCRiSta) computational pipeline; integrating sequence similarity searches, epitope prediction, homology modeling, and molecular dynamics simulations to de-risk and structurally stabilize vaccine candidates. As a case study, we applied VaCRiSta to the GCN4 trimerization domain in the context of the mumps F protein. The optimized sequence (GCN4_QM) eliminates 139 7-mer and 50 8-mer human proteome matches, is predicted to enhance stability of the trimeric F protein assembly and doubles protein expression yield (2.2 vs. 1.1 mg\/L) for a mumps vaccine candidate. GCN4_QM maintains structural integrity, confirmed by negative-stain electron microscopy, and elicits approximately 3-fold higher neutralizing antibody titers in mice (\n                  <italic>p<\/italic>\n                  \u2009&lt;\u20090.0407). GCN4_QM is a useful structural module for protein engineering and multimeric vaccine design, particularly in replacement of a transmembrane region to ensure the solubility of a trimeric protein. Accordingly, the VaCRiSta approach may support vaccine safety, stability and yield, potentially providing benefits for clinical efficacy and delivery to populations.\n                <\/p>","DOI":"10.21203\/rs.3.rs-7642777\/v1","type":"posted-content","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T09:43:22Z","timestamp":1759225402000},"source":"Crossref","is-referenced-by-count":0,"title":["A Computationally Optimised Structural Integrity Sequence Enhances Vaccine Stability, Yield and Safety Profile"],"prefix":"10.21203","author":[{"given":"Arthur","family":"Sarron","sequence":"first","affiliation":[{"name":"Queen\u2019s University Belfast"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun B.","family":"Sowers","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaroslav","family":"Tsybovsky","sequence":"additional","affiliation":[{"name":"Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Colley","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen N.","family":"Crooke","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume B. E.","family":"Stewart-Jones","sequence":"additional","affiliation":[{"name":"Mevox Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Overton","sequence":"additional","affiliation":[{"name":"Queen\u2019s University Belfast"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Patel, M.K., et al., Progress Toward Regional Measles Elimination - Worldwide, 2000\u20132018. MMWR Morb Mortal Wkly Rep, 2019. 68(48): p. 1105\u20131111.","DOI":"10.15585\/mmwr.mm6848a1"},{"key":"ref2","unstructured":"2. Owen, J., J. Punt, and S. Stranford, Immunologie\u22127e \u00e9dition: Le cours de Janis Kuby avec questions de r\u00e9vision. 2014: Dunod."},{"key":"ref3","unstructured":"3. Organization, W.H. Counting the impact of vaccines. 2021 [cited 2024 09\/04\/2024]; Available from: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/counting-the-impact-of-vaccines."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. Sim, S.Y., et al., Return On Investment From Immunization Against 10 Pathogens In 94 Low- https:\/\/pubmed.ncbi.nlm.nih.gov\/29503439\/And Middle-Income Countries, 2011\u201330. Health Affairs, 2020. 39(8): p. 1343\u20131353.","DOI":"10.1377\/hlthaff.2020.00103"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Jo, C., Cost-of-illness studies: concepts, scopes, and methods. Clinical and Molecular Hepatology, 2014. 20(4): p. 327.","DOI":"10.3350\/cmh.2014.20.4.327"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Segal, Y. and Y. Shoenfeld, Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cellular & Molecular Immunology, 2018. 15(6): p. 586\u2013594.","DOI":"10.1038\/cmi.2017.151"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"7. Rose, N.R., Negative selection, epitope mimicry and autoimmunity. Curr Opin Immunol, 2017. 49: p. 51\u201355.","DOI":"10.1016\/j.coi.2017.08.014"},{"key":"ref8","unstructured":"8. Kanduc, D., Quantifying the possible cross-reactivity risk of an HPV16 vaccine. J Exp Ther Oncol, 2009. 8(1): p. 65\u201376."},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Trost, B., et al., No human protein is exempt from bacterial motifs, not even one. Self\/Nonself, 2010. 1(4): p. 328\u2013334.","DOI":"10.4161\/self.1.4.13315"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Fa\u00e9, K.C., et al., How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. Journal of Autoimmunity, 2005. 24(2): p. 101\u2013109.","DOI":"10.1016\/j.jaut.2005.01.007"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Jumper, J., et al., Highly accurate protein structure prediction with AlphaFold. Nature, 2021. 596(7873): p. 583\u2013589.","DOI":"10.1038\/s41586-021-03819-2"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. David, A., et al., The AlphaFold Database of Protein Structures: A Biologist's Guide. J Mol Biol, 2022. 434(2): p. 167336.","DOI":"10.1016\/j.jmb.2021.167336"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Ruff, K.M. and R.V. Pappu, AlphaFold and Implications for Intrinsically Disordered Proteins. J Mol Biol, 2021. 433(20): p. 167208.","DOI":"10.1016\/j.jmb.2021.167208"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Bender, B.J., et al., Protocols for Molecular Modeling with Rosetta3 and RosettaScripts. Biochemistry, 2016. 55(34): p. 4748\u221263.","DOI":"10.1021\/acs.biochem.6b00444"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Dauparas, J., et al., Robust deep learning\u2013based protein sequence design using ProteinMPNN. Science, 2022. 378(6615): p. 49\u201356.","DOI":"10.1126\/science.add2187"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Bennett, N.R., et al., Improving de novo protein binder design with deep learning. Nature Communications, 2023. 14(1): p. 2625.","DOI":"10.1038\/s41467-023-38328-5"},{"key":"ref17","unstructured":"17. McLellan, J., et al., Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus, Science, 2013. 342(6158): p. 592-8."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Weinstein, J.J., et al., PROSS 2: a new server for the design of stable and highly expressed protein variants. Bioinformatics, 2021. 37(1): p. 123\u2013125.","DOI":"10.1093\/bioinformatics\/btaa1071"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Van Heeckeren, W.J., J.W. Sellers, and K. Struhl, Role of the conserved leucines in the leucine zipper dimerization motif of yeast GCN4. Nucleic Acids Research, 1992. 20(14): p. 3721\u20133724.","DOI":"10.1093\/nar\/20.14.3721"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Stewart-Jones G. B. E., et al., Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1\u20134. Proc Natl Acad Sci U S A, 2018. 115(48): p. 12265\u201312270.","DOI":"10.1073\/pnas.1811980115"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Loomis R.J., et al., Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development. Front Immunol., 2020. 11:842.","DOI":"10.3389\/fimmu.2020.00842"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Loomis R.J., et al., Structure-based design of glycoprotein subunit vaccines for mumps. Proc Natl Acad Sci U S A, 2024. 121(47)","DOI":"10.1073\/pnas.2404053121"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Rubin, S., et al., Molecular biology, pathogenesis and pathology of mumps virus. The Journal of Pathology, 2015. 235(2): p. 242\u2013252.","DOI":"10.1002\/path.4445"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Yin, H.-S., et al., Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proceedings of the National Academy of Sciences, 2005. 102(26): p. 9288\u20139293.","DOI":"10.1073\/pnas.0503989102"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Yin, H.-S., et al., Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature, 2006. 439(7072): p. 38\u201344.","DOI":"10.1038\/nature04322"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Altschul, S.F., et al., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research, 1997. 25(17): p. 3389\u20133402.","DOI":"10.1093\/nar\/25.17.3389"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Martin, F.J., et al., Ensembl 2023. Nucleic Acids Research, 2023. 51(D1): p. D933-D941.","DOI":"10.1093\/nar\/gkac1014"},{"key":"ref28","unstructured":"28. Bateman, A., et al., UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Research, 2023. 51(D1): p. D523-D531."},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Sievers, F., et al., Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular Systems Biology, 2011. 7(1): p. 539.","DOI":"10.1038\/msb.2011.75"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Waterhouse, A.M., et al., Jalview Version 2\u2013a multiple sequence alignment editor and analysis workbench. Bioinformatics, 2009. 25(9): p. 1189\u20131191.","DOI":"10.1093\/bioinformatics\/btp033"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Peters, B., M. Nielsen, and A. Sette, T Cell Epitope Predictions. Annual Review of Immunology, 2020. 38(1): p. 123\u2013145.","DOI":"10.1146\/annurev-immunol-082119-124838"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Xiao, Z., et al., Dual non-contiguous peptide occupancy of HLA class I evoke antiviral human CD8 T cell response and form neo-epitopes with self-antigens. Scientific Reports, 2017. 7(1).","DOI":"10.1038\/s41598-017-05171-w"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. Utsugi-Kobukai, S., et al., MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunology Letters, 2003. 89(2): p. 125\u2013131.","DOI":"10.1016\/S0165-2478(03)00128-7"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Robbins, P.D. and A.E. Morelli, Regulation of immune responses by extracellular vesicles. Nature Reviews Immunology, 2014. 14(3): p. 195\u2013208.","DOI":"10.1038\/nri3622"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"35. Ishina, I. A., et al. MHC Class II Presentation in Autoimmunity. Cells, 2023. 12(2): 314","DOI":"10.3390\/cells12020314"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. Lang, H.L.E., et al., A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immunology, 2002. 3(10): p. 940\u2013943.","DOI":"10.1038\/ni835"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Arase, N. and H. Arase, Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases. J Biochem, 2015. 158(5): p. 367\u221272.","DOI":"10.1093\/jb\/mvv093"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"38. Paul, S., et al., TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates. Current Protocols in Immunology, 2016. 114(1): p. 18.19.1\u221218.19.2.","DOI":"10.1002\/cpim.12"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Reynisson, B., et al., NetMHCpan\u22124.1 and NetMHCIIpan\u22124.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res, 2020. 48(W1): p. W449-w454.","DOI":"10.1093\/nar\/gkaa379"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Drozdetskiy, A., et al., JPred4: a protein secondary structure prediction server. Nucleic Acids Research, 2015. 43(W1): p. W389-W394.","DOI":"10.1093\/nar\/gkv332"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Linding, R., et al., GlobPlot: Exploring protein sequences for globularity and disorder. Nucleic Acids Res, 2003. 31(13): p. 3701\u22128.","DOI":"10.1093\/nar\/gkg519"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"42. Kyte, J. and R.F. Doolittle, A simple method for displaying the hydropathic character of a protein. Journal of Molecular Biology, 1982. 157(1): p. 105\u2013132.","DOI":"10.1016\/0022-2836(82)90515-0"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. Rice, P., I. Longden, and A. Bleasby, EMBOSS: The European Molecular Biology Open Software Suite. Trends in Genetics, 2000. 16(6): p. 276\u2013277.","DOI":"10.1016\/S0168-9525(00)02024-2"},{"key":"ref44","unstructured":"44. Corp, D.S.B., BIOVIA Discovery Studio Visualizer v21.1.0.20298. 2020."},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Webb, B. and A. Sali, Comparative Protein Structure Modeling Using MODELLER. Current Protocols in Bioinformatics, 2016. 54(1).","DOI":"10.1002\/cpbi.3"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. Berman, H.M., et al., The Protein Data Bank. Nucleic Acids Research, 2000. 28(1): p. 235\u2013242.","DOI":"10.1093\/nar\/28.1.235"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. Harbury, P.B., P.S. Kim, and T. Alber, Crystal structure of an isoleucine-zipper trimer. Nature, 1994. 371(6492): p. 80\u201383.","DOI":"10.1038\/371080a0"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. Wallace, A.C., R.A. Laskowski, and J.M. Thornton, LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, Design and Selection, 1995. 8(2): p. 127\u2013134.","DOI":"10.1093\/protein\/8.2.127"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. Petrauskas, V., E. Maximowitsch, and D. Matulis, Thermodynamics of Ion Pair Formations Between Charged Poly(Amino Acid)s. The Journal of Physical Chemistry B, 2015. 119(37): p. 12164\u201312171.","DOI":"10.1021\/acs.jpcb.5b05767"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. Musafia, B., V. Buchner, and D. Arad, Complex Salt Bridges in Proteins: Statistical Analysis of Structure and Function. Journal of Molecular Biology, 1995. 254(4): p. 761\u2013770.","DOI":"10.1006\/jmbi.1995.0653"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"51. F\u00e1g\u00e1in, C.\u00d3., Understanding and increasing protein stability. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995. 1252(1): p. 1\u201314.","DOI":"10.1016\/0167-4838(95)00133-F"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"52. Abraham, M.J., et al., GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 2015. 1\u20132: p. 19\u201325.","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"53. Duan, Y., et al., A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. Journal of Computational Chemistry, 2003. 24(16): p. 1999\u20132012.","DOI":"10.1002\/jcc.10349"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"54. Berendsen, H.J.C., et al., Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 1984. 81(8): p. 3684\u20133690.","DOI":"10.1063\/1.448118"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"55. Mastronarde D.N., et al., Automated electron microscope tomography using robust prediction of specimen movements. J Struct Biol, 2005, 152(1):36\u201351.","DOI":"10.1016\/j.jsb.2005.07.007"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"56. Scheres, S. H. W., et al. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol, 2012 180(3):519\u2009\u2212\u200930.","DOI":"10.1016\/j.jsb.2012.09.006"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"57. Fiebelkorn A.P., et al. Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum Infect Dis, 2014, 18;1(3):ofu094.","DOI":"10.1093\/ofid\/ofu094"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"58. Gonzalez-Galarza, Faviel F., et al., Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Research, 2019. 48(D1):D783-D788.","DOI":"10.1093\/nar\/gkz1029"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"59. Scheiblhofer, S., et al., Influence of protein fold stability on immunogenicity and its implications for vaccine design. Expert Review of Vaccines 2017 16(5):749\u2212489.","DOI":"10.1080\/14760584.2017.1306441"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"60. Olivieri, B., et al., Vaccinations and Autoimmune Disease. Vaccines 2021 9(8):815.","DOI":"10.3390\/vaccines9080815"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7642777\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7642777\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:23:55Z","timestamp":1763511835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7642777\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":60,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7642777\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,9,30]]},"subtype":"preprint"}}